Alcidion Group Limited ( (AU:ALC) ) has issued an announcement.
Alcidion Group Limited has announced its H1 FY25 results, highlighting its commitment to enhancing healthcare delivery through its Miya Precision platform. The platform’s real-time data capabilities are designed to improve clinical decision-making and patient safety, positioning Alcidion as a key player in the digital healthcare space. This announcement underscores the company’s strategic focus on leveraging technology to drive meaningful change in healthcare, potentially impacting stakeholders by advancing the efficiency and safety of healthcare services.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing smart technology solutions aimed at improving clinical decision-making and healthcare delivery. Their primary product, Miya Precision, is a platform that offers real-time interoperable data to support digital care, featuring components like Patient Flow Management, Clinical Decision Support, Electronic Patient Record, and Patient Administration System.
YTD Price Performance: 53.33%
Average Trading Volume: 1,479,364
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$123.6M
For detailed information about ALC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com